×

Seattle Genetics CEO on ADCETRIS Drug For Hodgkins

6:45 PM ET Tue, 5 June 2012

Clay Siegall, Seattle Genetics president & CEO, discusses his company's latest drug developments for non-hodgkins lymphoma and hodgkins lymphoma, and its opportunity to be a "$1 billion plus product on its own."